RBX1

E3 ubiquitin-protein ligase RBX1 · P62877 · RBX1 on Sugi Atlas →

0 patent compounds predicted against RBX1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RBX1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt PHASE4COMPLETED
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis PHASE2/PHASE3UNKNOWN
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers PHASE1/PHASE2COMPLETED
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes PHASE2UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors PHASE1COMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
ADAPT: Efficacy of a Dietary Supplement During and After Exercise nanCOMPLETED
Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions nanUNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Studying Health Outcomes After Treatment in Patients With Retinoblastoma nanRECRUITING
The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being nanUNKNOWN
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science nanRECRUITING
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
Establishment of a Prospective Clinical-biological Database nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RBX1 binder may also engage these)

ProteinNameSimilarity
P62878 1.000 P62878 →
Q8QG64 1.000 Q8QG64 →
Q9W5E1 0.976 Q9W5E1 →
Q940X7 0.946 Q940X7 →
Q54K33 0.928 Q54K33 →
Q24572 0.911 Q24572 →
Q13888 0.909 Q13888 →
Q5BJT2 0.909 Q5BJT2 →
Q9Z2M6 0.909 Q9Z2M6 →
Q2KHU8 0.909 Q2KHU8 →
C9WPN6 0.907 C9WPN6 →
Q7ZTY4 0.907 Q7ZTY4 →
Q2TBV5 0.906 Q2TBV5 →
Q2TA46 0.906 Q2TA46 →
P63073 0.906 P63073 →
Q9Z0N2 0.906 Q9Z0N2 →
P63074 0.906 P63074 →
AP3S1 AP-3 complex subunit sigma-1 0.905 landscape →
P81795 0.905 P81795 →
Q8AVH1 0.904 Q8AVH1 →
RPS7 Small ribosomal subunit protein eS7 0.904 landscape →
Q6P1K8 0.904 Q6P1K8 →
Q2YDH6 0.904 Q2YDH6 →
P41091 0.904 P41091 →
Q9DCR2 0.904 Q9DCR2 →
P20461 0.904 P20461 →
Q5HZM6 0.903 Q5HZM6 →
Q5ZMS3 0.903 Q5ZMS3 →
Q5RT64 0.902 Q5RT64 →
P62083 0.902 P62083 →